$105.96 +0.03 (%) Gilead Sciences Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD | Sep. 19, 2014 | 18:35PM EST
  2. Gilead's Zydelig Approved In EU; Imbruvica In Wings

    IBD | Sep. 19, 2014 | 12:17PM EST
  3. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Sep. 19, 2014 | 07:22AM EST
  4. 2 Columbia Growth Funds Notch Impressive Three-Month Performance

    Benzinga | Sep. 18, 2014 | 10:52AM EST
  5. Gilead Dips On Drug Setbacks

    IBD | Sep. 17, 2014 | 19:23PM EST
  6. Gilead Stock Is Falling On These Drug Setbacks

    IBD | Sep. 17, 2014 | 12:52PM EST
  7. This Top Growth Fund Leans Heavily On Large-Cap Tech

    Benzinga | Sep. 17, 2014 | 09:28AM EST
  8. Gilead Sciences

    IBD | Sep. 16, 2014 | 18:53PM EST
  9. Stocks Rise Ahead Of Fed, Led By Biotech, Chip Names

    IBD | Sep. 16, 2014 | 17:01PM EST
  10. Gilead Up As Analyst Lifts Sovaldi Q3 Estimate

    IBD | Sep. 16, 2014 | 13:57PM EST
  11. Stock Futures Mildly Lower; Netflix, Gilead Still Sliding

    IBD | Sep. 16, 2014 | 09:09AM EST
  12. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  13. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 16, 2014 | 08:11AM EST
  14. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  15. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  16. Morning Market Losers

    Benzinga | Sep. 15, 2014 | 09:48AM EST
  17. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2014 | 08:15AM EST
  18. #PreMarket Primer: Monday, September 15: Cameron Vows To Destroy ISIS

    Benzinga | Sep. 15, 2014 | 07:54AM EST
  19. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  20. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  21. 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 12, 2014 | 08:02AM EST
  22. Stocks Bounce As Nasdaq, S&P 500 Close With Small Gains

    IBD | Sep. 11, 2014 | 16:17PM EST
  23. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  24. Gilead Sciences, Inc. Could Be Taking A Break Before Even More Upside

    Benzinga | Sep. 10, 2014 | 15:05PM EST
  25. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  26. Stocks Up At Midday; Alexion Leads Biotech Rebound

    IBD | Sep. 10, 2014 | 11:54AM EST
  27. Under Armour, Apple, Gilead Among Big-Cap Leaders

    IBD | Sep. 10, 2014 | 08:02AM EST
  28. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  29. CNBC's Stock Pops & Drops From September 5

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  30. CNBC's Stock Pops & Drops From September 5: Control4 Corp, Priceline Group Inc & More

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  31. Allianz's Analyst Likes Biogen, Celgene & Gilead

    Benzinga | Sep. 6, 2014 | 17:28PM EST
  32. Fast Money Halftime Report Final Trade From September 5

    Benzinga | Sep. 6, 2014 | 17:26PM EST
  33. Meet 5 IBD 50 Stocks Expanding Into New Markets

    IBD | Sep. 6, 2014 | 08:01AM EST
  34. Gilead Dips On Cheap Drugs

    IBD | Sep. 5, 2014 | 19:24PM EST
  35. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  36. Why Gilead Is Falling On Drugs For Developing Nations

    IBD | Sep. 5, 2014 | 15:15PM EST
  37. Indexes Trim Losses But Remain Lower At Midday

    IBD | Sep. 5, 2014 | 12:04PM EST
  38. Stocks Sag In Light Trade; Taser Bolts Higher, Gilead Dips

    IBD | Sep. 5, 2014 | 10:33AM EST
  39. A Word On Healthcare Mutual Funds, And One Sector's 'Fittest' Segment

    Benzinga | Sep. 5, 2014 | 10:22AM EST
  40. Markets Edge Lower; Zumiez Issues Weak Outlook

    Benzinga | Sep. 5, 2014 | 10:21AM EST
  41. Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding

    Benzinga | Sep. 5, 2014 | 09:27AM EST
  42. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD | Sep. 3, 2014 | 18:28PM EST
  43. New Managers Revive Thrivent Large Cap Growth Fund

    IBD | Sep. 3, 2014 | 18:28PM EST
  44. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  45. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga | Sep. 2, 2014 | 10:05AM EST
  46. Mike Khouw's Gilead Sciences Trade

    Benzinga | Aug. 30, 2014 | 11:20AM EST
  47. What You Need to Know About the Roche-InterMune Deal

    Benzinga | Aug. 29, 2014 | 15:51PM EST
  48. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  49. Bristol-Myers Drug Gets OK

    IBD | Aug. 27, 2014 | 18:56PM EST
  50. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga | Aug. 27, 2014 | 15:22PM EST
Trading Center